Supervised clustering of peripheral immune cells associated with clinical response to checkpoint inhibitor therapy in patients with advanced melanoma

BACKGROUND AND PURPOSE: Immune therapy with checkpoint inhibitors (CPIs) is a highly successful therapy in many cancers including metastatic melanoma. Still, many patients do not respond well to therapy and there are no blood-borne biomarkers available to assess the clinical outcome. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kverneland, A.H., Thorsen, S.U., Granhøj, J.S., Hansen, F.S., Konge, M., Ellebæk, E., Donia, M., Svane, I.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558712/
https://www.ncbi.nlm.nih.gov/pubmed/37810199
http://dx.doi.org/10.1016/j.iotech.2023.100396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558712/
https://www.ncbi.nlm.nih.gov/pubmed/37810199
http://dx.doi.org/10.1016/j.iotech.2023.100396

Ejemplares similares